Inventor · disambiguated record
Yunfu Luo
Also filed as: LUO YUNFU
34 granted patents·20 pending applications·92 citations·filing 2011–2024
94Inventor score
Files withMERCK SHARP & DOHME19MEDSHINE DISCOVERY INC16CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD9SHIJIAZHUANG SAGACITY NEW DRUG DEV CO LTD2BOLEA CHRISTELLE1
Top patents by PatentIndex Score
54 records- 0196US10189831B2Non-nucleoside reverse transcriptase inhibitorsMERCK SHARP & DOHME·Filed 2017·Granted Jan 29, 2019·75 cites·17 claims
- 0283US9695163B2Thiazole orexin receptor antagonistsMERCK SHARP & DOHME·Filed 2014·Granted Jul 4, 2017·8 cites·14 claims
- 0380US11136315B2CXCR2 antagonistMEDSHINE DISCOVERY INC·Filed 2019·Granted Oct 5, 2021·2 cites·18 claims
- 0478US11905276B2Bicyclic compound that acts as CRBN protein regulatorMEDSHINE DISCOVERY INC·Filed 2020·Granted Feb 20, 2024·1 cites·11 claims
- 0577US11993596B2Fused tri-cyclic compound as PDE3/PDE4 dual inhibitorCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2019·Granted May 28, 2024·1 cites·21 claims
- 0673US2024294526A1Fused tri-cyclic compound as a pde3/pde4 dual inhibitorCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2024·Application pending·0 cites
- 0771US10662189B2PDE4 inhibitorSHIJIAZHUANG SAGACITY NEW DRUG DEV CO LTD·Filed 2017·Granted May 26, 2020·1 cites·31 claims
- 0871US10532986B2Cyclic compound acting as PDE4 inhibitorMEDSHINE DISCOVERY INC·Filed 2017·Granted Jan 14, 2020·1 cites·24 claims
- 0970US10150751B2Pyrrolidine orexin receptor antagonistsMERCK SHARP & DOHME·Filed 2015·Granted Dec 11, 2018·1 cites·9 claims
- 1070US9718819B2Non-nucleoside reverse transcriptase inhibitorsMERCK SHARP & DOHME·Filed 2016·Granted Aug 1, 2017·1 cites·19 claims
- 1167US9828368B2Oxazole orexin receptor antagonistsMERCK SHARP & DOHME·Filed 2014·Granted Nov 28, 2017·1 cites·12 claims
- 1260US2024400547A12,6-piperidinedione compound and application thereofMEDSHINE DISCOVERY INC·Filed 2022·Application pending·0 cites
- 1360US2024317696A1Alkyl carboxylic acid compounds and application thereofMEDSHINE DISCOVERY INC·Filed 2022·Application pending·0 cites
- 1460US2024317722A1Heteroaryl-3-piperidinedione compound and use thereofMEDSHINE DISCOVERY INC·Filed 2022·Application pending·0 cites
- 1559US2025127905A1Glutarimide compound and use thereofMEDSHINE DISCOVERY INC·Filed 2022·Application pending·0 cites
- 1659US2024409560A1Pyrimidine tricyclic derivative and pharmaceutical application thereofCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2022·Application pending·0 cites
- 1758US11325907B2Crystal form of 1H-imidazo[4,5-b]pyridine-2(3H)-one compound and preparation process thereforMEDSHINE DISCOVERY INC·Filed 2019·Granted May 10, 2022·0 cites·14 claims
- 1857US2024246985A1Crystal form of triazolopyridine-substituted indazole compound and preparation method thereforMEDSHINE DISCOVERY INC·Filed 2022·Application pending·0 cites
- 1956US2024360112A1Heterocycloalkyl compounds as CCR2 / CCR5 antagonistsWUXI LIFE FOUNTAIN BIOTECH CO LTD·Filed 2024·Application pending·0 cites
- 2055US12466816B2Fused cyclic compound capable of degrading protein and use thereofMEDSHINE DISCOVERY INC·Filed 2020·Granted Nov 11, 2025·0 cites·11 claims
- 2154US12338218B2Crystal form of benzimidazole-2-one compound, solvate thereof, crystal form of solvate thereof, and preparation method thereofMEDSHINE DISCOVERY INC·Filed 2020·Granted Jun 24, 2025·0 cites·7 claims
- 2254US2025230148A1Crystal of fused tricyclic derivative or pharmaceutically acceptable salt thereofCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2023·Application pending·0 cites
- 2353US2023257398A1Pyrimidine-based tricyclic compound and use thereofCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2021·Application pending·0 cites
- 2453US2021317109A1Tricyclic substituted piperidine dione compoundMEDSHINE DISCOVERY INC·Filed 2019·Application pending·0 cites
- 2552US2023158152A1Proteolysis regulator and method for using sameMEDSHINE DISCOVERY INC·Filed 2021·Application pending·0 cites
- 2651US11319330B2Tricyclic furan-substituted piperidinedione compoundMEDSHINE DISCOVERY INC·Filed 2019·Granted May 3, 2022·0 cites·15 claims
- 2751US9981969B2Imidazole derivatives and methods of use thereof for improving the pharmacokinetics of a drugMERCK SHARP & DOHME·Filed 2014·Granted May 29, 2018·0 cites·5 claims
- 2851US2023060174A1Pharmaceutical composition of tricyclic pde3/pde4 dual inhibitor compoundCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2021·Application pending·0 cites
- 2950US9975888B2Aryl linked imidazole and triazole derivatives and methods of use thereof for improving the pharmacokinetics of a drugMERCK SHARP & DOHME·Filed 2014·Granted May 22, 2018·0 cites·17 claims
- 3049US10745377B2Piperidine or piperazine linked imidazole and triazole derivatives and methods of useMERCK SHARP & DOHME·Filed 2014·Granted Aug 18, 2020·0 cites·8 claims
- 3149US10239838B2Heteroaryl orexin receptor antagonistsMERCK SHARP & DOHME·Filed 2015·Granted Mar 26, 2019·0 cites·4 claims
- 3247US2023123104A1Crystal of tricyclic compound acting on crbn protein and preparation method thereforCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2021·Application pending·0 cites
- 3346US12466817B2Pyridine derivative and application thereofNICOYA THERAPEUTICS SHANGHAI CO LTD·Filed 2021·Granted Nov 11, 2025·0 cites·8 claims
- 3445US11628168B2Medical application of pyrimidine sulfonamides derivativesCHINESE PLA GENERAL HOSPITAL·Filed 2019·Granted Apr 18, 2023·0 cites·11 claims
- 3545US11319305B2Pyrimidine sulfamide derivative and preparation method and medical application thereofSHIJIAZHUANG SAGACITY NEW DRUG DEV CO LTD·Filed 2018·Granted May 3, 2022·0 cites·19 claims
- 3645US9556202B2Sulfonamide derivatives and methods of use thereof for improving the pharmacokinetics of a drugMERCK SHARP & DOHME·Filed 2013·Granted Jan 31, 2017·0 cites·20 claims
- 3745US2023115817A1Crystal of pde3/pde4 dual inhibitor and use thereofCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2021·Application pending·0 cites
- 3845US2022119376A1Tricyclic compounds acting on crbn proteinsCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2019·Application pending·0 cites
- 3944US2013210807A1Tricyclic Compounds as Allosteric Modulators of Metabotropic Glutamate Receptors.LIVERTON NIGEL J·Filed 2011·Application pending·0 cites
- 4044US2023002360A1Heterocycloalkyl compounds as CCR2 / CCR5 antagonistsSHENZHEN LINGFANG BIOTECH CO LTD·Filed 2020·Application pending·0 cites
- 4143US12297192B2Crystal form of pyrimidine sulfonamide compound and preparation method thereforWUXI BIOCITY BIOPHARMACEUTICS CO LTD·Filed 2020·Granted May 13, 2025·0 cites·19 claims
- 4243US9920038B2Methyl oxazole orexin receptor antagonistsMERCK SHARP & DOHME·Filed 2015·Granted Mar 20, 2018·0 cites·11 claims
- 4342US11155523B2Biphenyl compound as CCR2/CCR5 receptor antagonistMEDSHINE DISCOVERY INC·Filed 2017·Granted Oct 26, 2021·0 cites·25 claims
- 4439US10227336B2Pyrazole orexin receptor antagonistsMERCK SHARP & DOHME·Filed 2015·Granted Mar 12, 2019·0 cites·13 claims
- 4538US10526336B2Fused heteroaryl derivatives as orexin receptor antagonistsMERCK SHARP & DOHME·Filed 2015·Granted Jan 7, 2020·0 cites·9 claims
- 4638US10214535B2Hydroxmethyl piperidine orexin receptor antagonistsMERCK SHARP & DOHME·Filed 2015·Granted Feb 26, 2019·0 cites·3 claims
- 4738US10155750B2Amidoethyl azole orexin receptor antagonistsMERCK SHARP & DOHME·Filed 2015·Granted Dec 18, 2018·0 cites·5 claims
- 4838US10010539B2Pyrazole, triazole and tetrazole orexin receptor antagonistsMERCK SHARP & DOHME·Filed 2015·Granted Jul 3, 2018·0 cites·14 claims
- 4937US10435398B2Oxazole orexin receptor antagonistsMERCK SHARP & DOHME·Filed 2015·Granted Oct 8, 2019·0 cites·13 claims
- 5037US10017504B2Piperidine isoxazole and isothiazole orexin receptor antagonistsMERCK SHARP & DOHME·Filed 2015·Granted Jul 10, 2018·0 cites·15 claims
Showing the top 50 of 54 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Yunfu Luo files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →